To date, the IHC characterization of MMR proteins expression represents a pivotal screening tool in the identification of patients with suspected Lynch syndrome (LS), a cancer predisposition syndrome inherited in an autosomal dominant manner and due to germline pathogenic variants in MMR genes [3,5,6,7]. Here, MRC1 is linked to Lynch syndrome.